Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroartemisinin tablets in systemic lupus erythematosus (phase II)
CTR20171440Phase 2Completed
- Sponsor
- Institute of Chinese Materia Medica
- Start
- Dec 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dihydroartemisinin in systemic lupus erythematosus (SLE), sponsored by Institute of Chinese Materia Medica. Started Dec 2017; status: completed.
02
Drugs
dihydroartemisinin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20171440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171440.